Key facts
- Consint’s last known valuation is $3.2M (Jan 2025).
- It has raised $1.0M; the latest was Early Stage VC ($450K) in Oct 2025.
- Notable investors include Venture Garage, Equanimity Investments, SEA Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Consint
- ·The full record, as it builds
Funding rounds
No funding rounds for Consint are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Consint
Developer of a fraud and risk management artificial intelligence platform designed to expand access to healthcare insurance by streamlining claim processes and clinical decisions, ensuring coverage for all. The company's system manages insurance, does patient health record summarization, and automates claims document submission and processing, along with using deep learning algorithms to identify, localize, segment, annotate, and measure the size of cancer nodules, enabling hospitals and insurance companies to maintain accuracy, efficiency, and cost-effectiveness while curbing fraudulent activities.
- Sector
- Healthcare
- HQ
- Noida, India
- Founded
- 2020
- Employees
- 31
- Website
- consint.ai/
- Ownership
- Privately Held (backing)
Consint doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Consint shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Consint in its N-PORT filings yet. We sweep new filings monthly.